Kimberly-Clark Corporation Dossier

Kimberly-Clark Corporation reported net sales of $4.16 billion and operating income of $592 million for the quarter ended June 30, 2025. The North America business segment served as the primary revenue driver, generating $2.73 billion during the reporting period.

Financial Highlights

* Net Sales: $4.16 billion

* Gross Profit: $1.46 billion

* Operating Income: $592 million

* Net Income: $509 million

* Diluted Earnings Per Share: $1.53

* Total Assets: $16.77 billion

* Total Debt: $7.24 billion

* Operating Cash Flow: $1.10 billion (Six Months Ended June 30, 2025)

Kimberly-Clark Corporation continues to execute its strategy through a focus on innovation and productivity gains, underscored by its 2024 Transformation Initiative. Management updated the full-year 2025 financial outlook, projecting organic sales growth between 4% and 5% and adjusted earnings per share in the range of $7.90 to $8.10. This guidance reflects expectations for resilient consumer demand and the contribution of new product launches, balanced against an... Sign in / Sign up to learn more about Kimberly-Clark Corporation

Continue your research by chatting with our AI financial analyst about Kimberly-Clark Corporation. Ask follow-up questions, request specific analysis, or explore investment scenarios. All insights are grounded in verified financial data and SEC filings.

Start your analysis with these investor-focused questions:

• Given the reported decrease in gross margin and a slight revenue decline for the period ending in FY2025, what specific productivity gains and cost-saving measures give Kimberly-Clark Corporation the confidence to raise its full-year 2025 outlook for organic sales and adjusted EPS?
• In FY2025, Kimberly-Clark Corporation's International Personal Care segment saw a 12.9% decrease in operating profit despite positive organic sales growth. What are the primary factors contributing to this significant margin pressure, and how does the company plan to address them?
• With a high debt-to-equity ratio of 5.16 and significant capital allocation towards shareholder returns in FY2025, how does Kimberly-Clark Corporation balance this financial leverage against the need for reinvestment and managing risks like input cost volatility?
• The North America segment's FY2025 operating profit was negatively impacted by divestitures and unfavorable pricing. How does this performance align with Kimberly-Clark Corporation's broader 'Powering Care' transformation strategy, and what does it suggest about the competitive dynamics in its largest market?
• Considering the intense competition from rivals like Procter & Gamble and Essity, how does Kimberly-Clark Corporation's innovation pipeline and the raised 2025 outlook position the company to defend its market share in key product categories?